Table 3. Quality of life after CRS/HIPEC relative to baseline.
| Year | Author | N | QOL relative to baseline |
||
|---|---|---|---|---|---|
| ≤3 months | 3-9 months | 12 months | |||
| 2001 | McQuellon | 64 | Baseline | Increased | Increased |
| 2004 | Alexander | 73 | Baseline | Baseline | NR |
| 2006 | Tuttle | 35 | Baseline | Increased | Increased |
| 2007 | McQuellon | 96 | Baseline | Increased | Increased |
| 2007 | Lim | 28 | Decreased | Baseline | NR |
| 2008 | McQuellon | 58 | Decreased | Increased | Increased |
| 2008 | Jess | 23 | Decreased | Baseline | Baseline |
| 2009 | Macri | 17 | Decreased | Baseline | NR |
| 2010 | Lim | 35 | Baseline | Baseline | Baseline |
| 2010 | Alves | 49 | Decreased | Baseline | Increased |
| 2011 | Hill | 62 | Decreased | Baseline | Baseline |
| 2013 | Argenta | 10 | Decreased | Decreased | NR |
| 2013 | Tsilimparis | 99 | Decreased | Baseline | Baseline |
| 2014 | Passot | 216 | Decreased | Decreased | Baseline |
| 2014 | Albertsmeier | 40 | Decreased | Baseline | NR |
CRS/HIPEC, cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion; QOL, quality of life; NR, not reported.